- Home
- FSI vs SNTI Comparison
FSI vs SNTI Comparison
Compare FSI & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSI
- SNTI
- Stock Information
- Founded
- FSI 1991
- SNTI 2016
- Country
- FSI Canada
- SNTI United States
- Employees
- FSI N/A
- SNTI N/A
- Industry
- FSI Recreational Games/Products/Toys
- SNTI Biotechnology: Pharmaceutical Preparations
- Sector
- FSI Consumer Discretionary
- SNTI Health Care
- Exchange
- FSI Nasdaq
- SNTI Nasdaq
- Market Cap
- FSI 55.6M
- SNTI 50.3M
- IPO Year
- FSI 1999
- SNTI N/A
- Fundamental
- Price
- FSI $5.19
- SNTI $1.68
- Analyst Decision
- FSI
- SNTI Strong Buy
- Analyst Count
- FSI 0
- SNTI 2
- Target Price
- FSI N/A
- SNTI $8.50
- AVG Volume (30 Days)
- FSI 32.6K
- SNTI 510.8K
- Earning Date
- FSI 08-13-2025
- SNTI 08-12-2025
- Dividend Yield
- FSI 1.93%
- SNTI N/A
- EPS Growth
- FSI N/A
- SNTI N/A
- EPS
- FSI 0.18
- SNTI N/A
- Revenue
- FSI $36,483,680.00
- SNTI N/A
- Revenue This Year
- FSI $14.71
- SNTI N/A
- Revenue Next Year
- FSI $51.14
- SNTI $150.00
- P/E Ratio
- FSI $28.59
- SNTI N/A
- Revenue Growth
- FSI N/A
- SNTI N/A
- 52 Week Low
- FSI $1.65
- SNTI $1.52
- 52 Week High
- FSI $7.24
- SNTI $16.94
- Technical
- Relative Strength Index (RSI)
- FSI 47.94
- SNTI 29.38
- Support Level
- FSI $4.61
- SNTI $1.86
- Resistance Level
- FSI $5.49
- SNTI $2.12
- Average True Range (ATR)
- FSI 0.38
- SNTI 0.14
- MACD
- FSI -0.09
- SNTI -0.00
- Stochastic Oscillator
- FSI 41.30
- SNTI 12.00
About FSI Flexible Solutions International Inc. (CDA)
Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The firm also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.